Open Access Journal

ISSN : 2456-1304 (Online)

International Journal of Engineering Research in Electronics and Communication Engineering(IJERECE)

Monthly Journal for Electronics and Communication Engineering

Open Access Journal

International Journal of Science Engineering and Management (IJSEM)

Monthly Journal for Science Engineering and Management

ISSN : 2456-1304 (Online)

Covid-19-A Baleful Aftermath for the Stocks of Indian Pharmaceutical Companies

Author : Mayank Gangwani 1 Dhun Sehrawat 2

Date of Publication :24th September 2022

Abstract: Covid-19 catastrophe has not spared any market across the world due to widespread disruptions in its supply chain operations. In today's world, however, stock markets serve as a catalyst for a country's economic and financial development. But, with the development of Covid-19 infection and widespread lockdown in the majority of countries, its stock market has plummeted even further into the depths. Therefore, to determine whether the Covid-19 outbreak has impacted the expected return of Nifty Pharma and stock return of 3 leading pharmaceutical companies Cipla, Dr. Reddy's, and Sun Pharma in the before-Covid-19 period (1 Jan 2019 to 20 Mar 2020) and the after-Covid-19 period (23 Mar 2020 to 20 Mar 2021) this study is being carried out. The study aims to uncertain whether there exists a meaningful link between the S&P CNX Nifty index's forecasted market return and the expected security return of Nifty Pharma before and after Covid-19. To evaluate the relevant hypotheses, descriptive statistics event study technique, non-parametric testing, particularly the Wilcoxon Signed test, and regression analysis were used. It was discovered that the expected returns of Nifty Pharma and the expected security returns of Cipla, Dr. Reddy's, and Sun Pharma did not vary significantly before and throughout the Covid-19 epidemic period. However, for both before and throughout the Covid-19 era, there was a link between the predicted market return of the S&P CNX Nifty index and the security return of Nifty Pharma, implying that the benchmark index S&P CNX Nifty was influenced by Nifty Pharma's performance.

Reference :

    1. Amuthan, R. (2021). Co relating NIFTY 50 Index Trend’s impact on NSE’s Sector based Indices Growth Momentum in Post COVID-19 led Indian Economy with Special reference to NIFTY Bank, NIFTY Consumer Durables, NIFTY IT and NIFTY Pharma Indices using Arithmetic Modelling. Turkish Journal of Computer and Mathematics Education (TURCOMAT), 12(6), 2184-2189.
    2. Anh, D. L. T., & Gan, C. (2020). The impact of the COVID-19 lockdown on stock market performance: evidence from Vietnam. Journal of Economic Studies.
    3. Aravind M, Manojkrishnan C (2020). COVID19: Effect on Leading Pharmaceutical Stocks Listed with NSE. International Journal of Research in Pharmaceutical Sciences. 11(1): 31-36.
    4. Baldwin, R., & Di Mauro, B. W. (2020). Economics in the time of COVID-19: A new eBook. VOX CEPR Policy Portal.
    5. Behera, C., & Rath, B. N. (2021). The COVID-19 Pandemic and Indian Pharmaceutical Companies: An Event Study Analysis. Bulletin of Monetary Economics and Banking, Special, (2021), 1-14.
    6. Economic Times 2020. Covid-19 Impact: Fears of Chinese API shortage hurt pharma players; Glenmark Pharmaceuticals was the biggest loser on the healthcare index.
    7. Gopalakrishnan, M. M., Vijay, A. K. K. 2017. A Study on Risk-Return Analysis of Pharmaceutical Industries in the Indian Stock Market. Imperial Journal of Interdisciplinary Research, 3(5):1869–1874.
    8. International Air Transport Association (IATA) (2020). COVID-19 puts over half of 2020 passenger revenues at risk. Retrieved from 
    9. International Monetary Fund, (2020), World Economic Outlook: a long and difficult ascent, Washington, DC. October.
    10. Kebriaeezadeh, A., Zartab, S., Fatemi, S. F., & Radmanesh, R. (2013). Fundamentals and stock return in pharmaceutical companies: A panel data model of Iranian industry. Iranian Journal of Pharmaceutical Sciences, 9(1), 55-60.
    11. Lynch, H., Page, S., Panariello, R. A., Tzitzouris Jr, J. A., & Giroux, D. (2019). The revenge of the stock pickers. Financial Analysts Journal, 75(2), 34-43.
    12. Mckinsey&Company (2020). India Pharma 2020 Propelling access and acceptance, realizing true potential. (Available at: _service/Pharma%20and%20Medical%20Products/PMP%20 NEW/PDFs/778886_India_Pharma_2020_Propelling_Access _and_Accepta nce_Realising_True_Potential.ashx).
    13. Mittal, S., & Sharma, D. (2021). The Impact of COVID-19 on Stock Returns of the Indian Healthcare and Pharmaceutical Sector. Australasian Accounting, Business and Finance Journal, 15(1), 5-21.
    14. Ozili, P. K. (2020). Covid-19 pandemic and economic crisis: The Nigerian experience and structural causes. Journal of Economic and Administrative Sciences.
    15. Pathak, V (2020). A Study of Measuring Covid-19 Impact on Stock Performance of Selected Sectors.
    16. Press Information Bureau (PIB) (2021). PIB’s Special Webpage on COVID19. Government of India
    17. Saini, R. (2020). The impact of Corona Virus on Indian Economy. Available at SSRN 3595300.
    18. Soni, C. M. (2021). IMPACT OF COVID 19 PANDEMIC ON STOCK MARKET. PalArch's Journal of Archaeology of Egypt/Egyptology, 18(4), 7706-7712.
    19. Tashanova, D., Sekerbay, A., Chen, D., Luo, Y., Zhao, S., & Zhang, T. (2020). Investment opportunities and strategies in an era of Coronavirus pandemic. Available at SSRN 3567445.
    20. World Bank. (2021). World Development Report 2021: Data for Better Lives. The World Bank.
    21. Zeren, F., & HIZARCI, A. (2020). The impact of COVID-19 corona virus on stock markets: evidence from selected countries. Muhasebe ve Finans Ä°ncelemeleri Dergisi, 3(1), 78-84.

Recent Article